Document is current
Any future updates will be listed below
-
Authors
Draelos, Zoe D.
Kyeremateng, Kizito
Squittieri, Nicholas
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct06415279 at ClinicalTrials.govDocuments that mention this clinical trial
Reduction in Facial Sebum Production Following Treatment with Clascoterone Cream 1% in Patients with Acne Vulgaris: 12-Week Interim Analysis
https://doi.org/10.1007/s13555-025-01495-y
-
Funding
Funding for this research was provided by:
Sun Pharma
- License Information
-
More Information
Article History
Received: 30 May 2025
Accepted: 8 July 2025
First Online: 19 July 2025
Declarations
:
: Zoe D. Draelos was an investigator on this study and received a grant from Sun Pharma. She is also an editorial board member of Dermatology and Therapy. Zoe D. Draelos was not involved in the selection of peer reviewers for the manuscript, nor in any of the subsequent editorial decisions. Kizito Kyeremateng and Nicholas Squittieri are employees of Sun Pharmaceutical Industries, Inc.
: The study was conducted in accordance with Good Clinical Practice guidelines and all local legal and regulatory requirements and was registered with ClinicalTrials.gov (NCT06415279). Institutional review board (Allendale Institutional Review Board, Old Lyme, CT) approval was obtained for the study protocol. All patients (and/or a legally acceptable representative, as applicable) were required to provide written informed consent to participate in the study.
